menu
    • menu

    Company profile for Ottimo Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ottimo Pharma is pioneering first-in-class, uniquely designed, and differentiated wide-therapeutic index PD1/VEGFR2 bifunctional medicines to extend the lives of people living with cancer. Ottimo Pharma raised over $140 million in Series A financing to advance its innovative oncology therapeutics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ottimo Pharmaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Kreston Reeves Llp Innovation House, Ramsgate Road, Sandwich, Kent
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ottimopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Asimov, Ottimo Pharma Enter Cell Line Development Partnership
    Asimov, Ottimo Pharma Enter Cell Line Development Partnership

    27 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/asimov-ottimo-pharma-enter-cell-line-development-partnership/

    CONTRACTPHARMA
    27 Aug 2025
    Share Share
    Lotte Biologics Signs Antibody Manufacturing Contract with Ottimo
    Lotte Biologics Signs Antibody Manufacturing Contract with Ottimo

    20 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lotte-biologics-signs-antibody-manufacturing-contract-with-ottimo-pharma-302485822.html

    PR NEWSWIRE
    20 Jun 2025
    Share Share
    Ottimo Pharma appoints Roger Dansey, M.D. to Board of Directors
    Ottimo Pharma appoints Roger Dansey, M.D. to Board of Directors

    10 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/10/3059177/0/en/Ottimo-Pharma-Strengthens-Board-with-Appointment-of-Roger-Dansey-M-D-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    10 Apr 2025
    Share Share
    Ottimo Pharma boosts leadership with senior Appointments
    Ottimo Pharma boosts leadership with senior Appointments

    25 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ottimo-pharma-strengthens-leadership-team-with-senior-appointments-302383595.html

    PR NEWSWIRE
    25 Feb 2025
    Share Share
    Ottimo raises $140M to ready PD1/VEGFR2 antibody for clinic
    Ottimo raises $140M to ready PD1/VEGFR2 antibody for clinic

    19 Dec 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/former-seagen-ceos-biotech-raises-140m-series-ready-pd1vegfr2-antibody-clinic

    FIERCE BIOTECH
    19 Dec 2024
    Share Share
    Ottimo Pharma Raises over $140 Million in Series A Financing
    Ottimo Pharma Raises over $140 Million in Series A Financing

    19 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ottimo-pharma-raises-over-140-million-in-series-a-financing-302335274.html

    PR NEWSWIRE
    19 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search